Kirkland & Ellis International LLP is advising Advent International on the financing aspects of its €1.919 billion acquisition of leading European generics business Zentiva from global biopharmaceutical company Sanofi. Headquartered in Prague in the Czech Republic, Zentiva services over 40 million patients in 25 European countries. The transaction, which was announced on April 17, 2018, is expected to close by the end of 2018.
More information is available here.
The Kirkland team, in London, is being led by debt finance partners Christopher Shield and Hugh O’Sullivan and capital markets partner Matthew Merkle.